Breaking News | China’s First Diffractive EDoF IOL — Wanshian® Ultra‑EDoF IOL Launches-Company News-News

Recently, the world‑first and China‑first Wanshian® Ultra‑EDoF (Registration No.: NMPA Registration 20253162048) has been grandly launched! Building on years of technological accumulation, this product is another innovative medical device approved by the company, following the approval of China’s first Trifocal‑Plus intraocular lens, an innovative medical device.

Wanshian® Ultra‑EDoF introduces six diffractive optical orders for the first time, maximizing light‑energy utilization to achieve an ultra‑extended depth of focus. It helps patients achieve continuous, uninterrupted and all‑day‑round high‑quality vision.

World‑First Innovation

Wanshian® Ultra‑EDoF Intraocular Lens

Redefine Visual Quality

万视安®Ultra-EDoF搭载了多级次焦深延长技术，实现视程连续，带来2.32D超宽焦深、更优远中视力、极低光学干扰三大核心优势。Wanshian® Ultra‑EDoF adopts multi‑order extended depth‑of‑focus technology to deliver continuous visual range. It features three core advantages: an ultra‑wide depth of focus of 2.32 D, superior far‑to‑intermediate vision, and minimal optical disturbance.

Ultra‑Wide

Depth‑of‑Focus of 2.32 D

Broader Visual Experience

术后12个月视力达0.2LogMAR的受试者焦深平均值达2.32D，试验组优于对照组，从远距到中距无缝衔接，带来更广阔的视觉体验。

Superior

Far‑to‑Intermediate Vision

Smooth, Continuous & High‑Quality Vision

Wanshian® Ultra‑EDoF delivers excellent far vision comparable to monofocal IOLs, smooth and continuous visual range, and near‑trifocal‑like full‑range functional spectacle‑independent vision, meeting the higher‑quality‑of‑life demands of middle‑aged and elderly patients.

Minimal Optical Disturbance

Consistent Day‑and‑Night Visual Performance

Wanshian® Ultra‑EDoF achieves a light‑energy utilization rate of over 90 %, with far lower optical disturbance than comparable products. Clinical trial results show: At 6‑month post‑operation, 100 % of subjects in the test group reported satisfaction with both daytime and nighttime vision. It delivers outstanding low‑glare performance at night; the proportion of subjects reporting “never” or “rarely” experiencing glare reached 97.5 %, enabling consistent visual quality day and night.

China’s First Diffractive EDoF IOL

Innovative Medical Device Gains Wide Attention

On April 19, 2024, the National Medical Products Administration (NMPA) published the Public Announcement of Review Results for Special Review Applications for Innovative Medical Devices (No. 4, 2024) on its official website. Wanshian® Ultra‑EDoF officially entered the NMPA Special Review Procedure for Innovative Medical Devices, demonstrating its outstanding value in scientific‑technological innovation and clinical application. To date, Wanshian® Ultra‑EDoF remains China’s first innovative medical device among diffractive extended‑depth‑of‑focus intraocular lenses. With this achievement, Century Healthcare has become one of the very few domestic manufacturers holding two innovative‑medical‑device certifications for functional intraocular lenses.

Selected for Tianjin Major Special‑Project Program

Set New Heights for the Industry

December 2024, the Tianjin Municipal Science and Technology Bureau released the project approval list for the 2024 Tianjin Major Special‑Program for Public Health and Biomedicine. Tianjin Century Healthcare Biomedical Engineering Co., Ltd. was included in the list. Wanshian® Ultra‑EDoF Intraocular Lens is the product selected under the sub‑project titled "Accelerating the Industrialization of Products in the National Innovative Medical Device Catalogue".

Less than one year later, the product successfully obtained marketing approval for launch.

It represents not only another milestone for Century Healthcare in the field of premium refractive intraocular lenses, but also establishes the company as one of the very few hard‑technology enterprises in Tianjin to have secured multiple approvals for innovative medical devices. This has greatly enhanced the brand awareness and market influence of “Century Healthcare” within the high‑end medical market. It breaks the long‑standing competitive landscape dominated by international brands in this sector, accomplishing the leap from technological follow‑up to taking the lead in core fields. It fully demonstrates the strong momentum of domestic enterprises in advancing ophthalmic medical progress and fostering new‑quality productive forces.

Thanks and Gratitude

Grateful for Our Roots, Thankful for All Support.

The successful launch of Wanshian® Ultra‑EDoF Intraocular Lens would not have been possible without the generous support from all parties.

We sincerely thank the R&D team of Century Healthcare for their years‑long dedicated research and technical breakthroughs. It is your continuous exploration of optical limits and unwavering pursuit of patients’ visual quality that have brought this world‑first outstanding product to fruition and accomplished the great leap from concept to reality.

We sincerely appreciate all experts and physicians who participated in the clinical trials. The rigorous scientific attitude, detailed clinical observations and valuable professional insights from clinical practitioners have provided solid clinical evidence for the excellent post‑operative visual quality and safety profile of Wanshian® Ultra‑EDoF Intraocular Lens, enabling innovative technology to truly benefit patients.

We would also like to express our deepest gratitude for national and local supportive policies for innovative medical devices. We thank the Tianjin Municipal People’s Government, Tianjin Medical Products Administration, Tianjin Municipal Science and Technology Bureau, Binhai New Area Science and Technology Bureau, TEDA Administrative Committee and other competent authorities at all levels for their profound care and strong support, as well as extensive assistance and encouragement from all sectors of society. From being selected into the Tianjin Major Science and Technology Special‑Program to expeditiously passing the special review for innovative medical devices, every milestone relies on a favorable innovation ecosystem and efficient, pragmatic guidance. This serves as a solid backing that allows Century Healthcare to forge ahead whole‑heartedly toward new technical heights.

On this occasion, we take the launch of Wanshian® Ultra‑EDoF Intraocular Lens as a tribute to all who have shown us care, support and trust!

Looking Ahead

Clear Vision, Without Limits

Looking ahead, Century Healthcare will continue to uphold its R&D philosophy of “Innovation‑Driven, Quality‑Oriented”. The company will keep delving deep into intraocular lens technologies, bring more domestic high‑end medical products to the global market, and deliver higher‑quality, more human‑centric vision‑health solutions for patients worldwide. Wanshian® Ultra‑EDoF is only the beginning: Clear Vision, Without Limits!